BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3010476)

  • 1. Detection and quantitation of fetomaternal hemorrhage.
    Turner WA; Fadel HE; Krauss JS
    South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases of massive fetomaternal hemorrhage presenting without clinical suspicion.
    Pourbabak S; Rund CR; Crookston KP
    Arch Pathol Lab Med; 2004 Apr; 128(4):463-5. PubMed ID: 15043456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting fetomaternal hemorrhage: a comparison of five methods.
    Bayliss KM; Kueck BD; Johnson ST; Fueger JT; McFadden PW; Mikulski D; Gottschall JL
    Transfusion; 1991 May; 31(4):303-7. PubMed ID: 1850569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
    Ramsey G;
    Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
    Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
    Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women.
    Stedman CM; Baudin JC; White CA; Cooper ES
    Am J Obstet Gynecol; 1986 Jun; 154(6):1363-9. PubMed ID: 3013010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of fetomaternal hemorrhage.
    Kim YA; Makar RS
    Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
    Post GR; Lazarchick J; Singh ZN
    Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage.
    Ness PM; Baldwin ML; Niebyl JR
    Am J Obstet Gynecol; 1987 Jan; 156(1):154-8. PubMed ID: 3026183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.
    Kumpel B; Hazell M; Guest A; Dixey J; Mushens R; Bishop D; Wreford-Bush T; Lee E
    Transfusion; 2014 May; 54(5):1305-16. PubMed ID: 24236535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of estimation of volume of fetomaternal hemorrhage using Kleihauer-Betke test and microcolumn gel method in D-negative nonisoimmunized mothers.
    Mittal K; Marwaha N; Kumar P; Saha SC; Thakral B
    Immunohematology; 2013; 29(3):105-9. PubMed ID: 24325171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of Rh alloimmunization. Fact or fancy?
    Bowman JM; Pollock JM
    Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
    Hensleigh PA
    Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin].
    Baiochi E; Camano L; Bordin JO
    Cad Saude Publica; 2005; 21(5):1357-65. PubMed ID: 16158140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of maternal isoimmunization to RhD antigen].
    Baptista González HA; Rosenfeld Mann F
    Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.